Literature DB >> 3158820

Interleukin-2 stimulates association of protein kinase C with plasma membrane.

W L Farrar, W B Anderson.   

Abstract

Interleukin-2 (IL-2) is a regulatory peptide important for the growth and differentiation of antigen-specific T lymphocytes and large granular lymphocytes. Interaction of IL-2 with its specific receptor results in the promotion of S-phase progression as well as, in certain circumstances, the production and release of gamma-interferon (IFN-gamma). Although the binding of IL-2 with high-affinity specific receptors has been well characterized, the intracellular mechanisms by which this ligand-receptor interaction promotes growth and differentiation are unknown. Here, we present evidence that IL-2/receptor interaction produces a rapid and transient redistribution of protein kinase C (PK-C) from the cytosol to the plasma membrane. Phorbol myristate acetate (PMA) also induces PK-C transposition in an analogous manner, except that PMA-induced PK-C transposition to the plasma membrane is apparently protracted. As phorbol esters have been shown to mimic IL-2 in the regulation of cellular proliferation as well as IFN-gamma production, the activation of PK-C by either phorbol esters or IL-2/receptor interaction seems to have a crucial role in signal transduction elicited by these extracellular messengers.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158820     DOI: 10.1038/315233a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  64 in total

1.  Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in cancer cell migration.

Authors:  Nikki A Evensen; Cem Kuscu; Hoang-Lan Nguyen; Kevin Zarrabi; Antoine Dufour; Pournima Kadam; You-Jun Hu; Ashleigh Pulkoski-Gross; Wadie F Bahou; Stanley Zucker; Jian Cao
Journal:  J Natl Cancer Inst       Date:  2013-08-29       Impact factor: 13.506

2.  Intracytoplasmic phosphorylation sites of Tac antigen (p55) are not essential for the conformation, function, and regulation of the human interleukin 2 receptor.

Authors:  M Hatakeyama; S Minamoto; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Cloned T-cell proliferation and synthesis of specific proteins are inhibited by quinine.

Authors:  D E Sabath; D S Monos; S C Lee; C Deutsch; M B Prystowsky
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

4.  Regulation of IL-4 lymphokine gene expression and cellular proliferation in murine T helper type II cells.

Authors:  E Muñoz; A M Zubiaga; J Muñoz; B T Huber
Journal:  Cell Regul       Date:  1990-04

5.  Interleukin-2 lengthens extrajunctional acetylcholine receptor channel open time in mammalian muscle cells.

Authors:  P Lorenzon; F Ruzzier; C G Caratsch; A Giovannelli; F Velotti; A Santoni; F Eusebi
Journal:  Pflugers Arch       Date:  1991-10       Impact factor: 3.657

6.  Induction of a cytoplasmic activator of DNA synthesis in lymphocytes is mediated through a membrane-associated protein kinase.

Authors:  M V Autieri; K L Fresa; F D Coffman; M E Katz; S Cohen
Journal:  Cell Regul       Date:  1990-12

7.  Antigen-receptor interaction requirement for conjugate formation and lethal-hit triggering by cytotoxic T lymphocytes can be bypassed by protein kinase C activators and Ca2+ ionophores.

Authors:  G Berrebi; H Takayama; M V Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

8.  The role of class I histocompatibility antigens in the regulation of T-cell activation.

Authors:  J D Dasgupta; K Cemach; D P Dubey; E J Yunis; D B Amos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

Review 9.  Calcium, cyclic AMP and protein kinase C--partners in mitogenesis.

Authors:  J F Whitfield; J P Durkin; D J Franks; L P Kleine; L Raptis; R H Rixon; M Sikorska; P R Walker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 10.  Therapeutic potential of protein kinase C inhibitors.

Authors:  D Bradshaw; C H Hill; J S Nixon; S E Wilkinson
Journal:  Agents Actions       Date:  1993-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.